2018 American Transplant Congress
Cytomegalovirus Prophylaxis Following Alemtuzumab Induction in High Risk Renal Transplant Recipients Experiencing Delayed Graft Function
University of Maryland, Baltimore.
Purpose: There is limited data to support the use of valganciclovir in patients on dialysis. This study assessed the efficacy of valganciclovir 450 mg twice…2018 American Transplant Congress
Clinical Utility of CMV-Specific CD8+ T-Cell Immune Competence Score in Lung and Heart-Lung Transplant Recipients at Risk of Cytomegalovirus Infection
Introduction: Cytomegalovirus (CMV) is a common infection that causes significant morbidity among lung and heart-lung (LHL) transplant recipients. We determined the clinical utility of global…2018 American Transplant Congress
Timing of Infections after Total Artificial Heart Implantation. What Did We Learn?
Transplant Infectious Diseases, University of Nebraska Medical Center, Omaha, NE.
Background: The total artificial heart (TAH) has become a reliable bridge to heart transplantation. There are no studies describing the timing of infections post-TAH implantation.…2018 American Transplant Congress
Latent Tuberculosis Diagnosis Prior to Kidney Transplantation in a High Burden Country: Improvement with Serological Tests
Nephrology and Kidney Transplant Department, ISCMPA, Porto Alegre, Brazil.
Introduction: Diagnosing and treating tuberculosis after kidney transplantation is challenging, and mortality is high. In an epidemiological study performed at our Center, there was an…2018 American Transplant Congress
The TRANSFORM Study: Infection Outcomes with Everolimus Plus Reduced Calcineurin Inhibitor and Mycophenolate Plus Standard Calcineurin Inhibitor Regimens in De Novo Kidney Transplant Recipients
TRANSFORM Study Group, Novartis Pharma AG, Basel, Switzerland.
Purpose: Post-transplant (Tx) bacterial and viral infections are known to affect graft and patient survival. Accumulating evidence supports the protective effect of everolimus (EVR) against…2018 American Transplant Congress
A Multi-Center Analysis of Risk Factors for Pneumocystis Pneumonia (PCP) in Solid Organ Transplant Recipients
Medicine, London Health Sciences Centre (LHSC), London, ON, Canada.
Introduction: Pneumocystis pneumonia (PCP) is associated with morbidity and mortality in solid organ transplant patients (SOTs). There are increasing reports of late PCP in SOT…2018 American Transplant Congress
Using Machine Learning and Simulation to Compare High Risk Kidney Transplant Survival to Waiting for a Non High Risk Organ
The purpose of this study is to help patients decide whether to accept a kidney from a donor with a potential disease. We consider infectious…2018 American Transplant Congress
Optimal Anti-Thymocyte Globulin Dose for Induction Immunosuppression in Kidney Transplantation
Organ Transplant Program, Swedish Medical Center, Seattle, WA.
Anti-thymocyte globulin (ATG) is used as induction immunosuppression in kidney transplantation to prevent allograft rejection. ATG causes dose-dependent lymphocyte depletion, yet optimal dose is unknown.…2018 American Transplant Congress
Surveillance for Mycoplasma/Ureaplasma Infection in Lung Transplant Recipients (LTRs)
University of Alberta, Edmonton, AB, Canada.
Introduction: An association with Ureplasma urealyticum, Ureaplasma parvum and Mycoplasma hominis infections has been proposed to play a causative role in hyperammonemia syndrome (HS), a…2018 American Transplant Congress
Prevalence and Infection-Related Outcomes Associated with Transplant Tourism
Transplant Infectious Diseases, Toronto General Hospital, Toronto, ON, Canada.
Background:Patients who receive organ transplants via transplant tourism may have a greater risk of complications. We sought to describe the infectious risks associated with this…
- « Previous Page
- 1
- …
- 52
- 53
- 54
- 55
- 56
- …
- 84
- Next Page »